Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia.

Conclusion. FCM was well tolerated and effectively increased mean hemoglobin levels in postpartum women or women with heavy menstrual bleeding and IDA. This trial is registered with ClinicalTrials.gov, NCT00548860. PMID: 28487769 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/28487769?dopt=Abstract

Source: Anemia - May 12, 2017 Category: Hematology Tags: Anemia Source Type: research